Encompass Health Stock Forecast, Price & News

+0.38 (+0.46 %)
(As of 07/30/2021 04:15 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume426,642 shs
Average Volume608,951 shs
Market Capitalization$8.29 billion
P/E Ratio27.30
Dividend Yield1.35%
30 days | 90 days | 365 days | Advanced Chart
Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

Encompass Health logo

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of June 14, 2021, it operated 140 hospitals, 250 home health locations, and 93 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.34 out of 5 stars

Medical Sector

67th out of 2,216 stocks

Hospitals Industry

2nd out of 10 stocks

Analyst Opinion: 2.5Community Rank: 3.8Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Encompass Health (NYSE:EHC) Frequently Asked Questions

Is Encompass Health a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health
or view top-rated stocks.

What stocks does MarketBeat like better than Encompass Health?

Wall Street analysts have given Encompass Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Encompass Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Encompass Health?

Encompass Health saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,350,000 shares, an increase of 16.9% from the June 30th total of 2,010,000 shares. Based on an average daily volume of 555,900 shares, the short-interest ratio is currently 4.2 days. Approximately 2.4% of the shares of the company are short sold.
View Encompass Health's Short Interest

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Encompass Health

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) released its quarterly earnings results on Monday, July, 26th. The company reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $0.98 by $0.19. The company had revenue of $1.29 billion for the quarter, compared to analyst estimates of $1.28 billion. Encompass Health had a trailing twelve-month return on equity of 15.89% and a net margin of 6.49%. The company's revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.34 earnings per share.
View Encompass Health's earnings history

How has Encompass Health's stock been impacted by COVID-19?

Encompass Health's stock was trading at $63.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EHC shares have increased by 30.4% and is now trading at $83.25.
View which stocks have been most impacted by COVID-19

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Tuesday, July 20th. Investors of record on Friday, October 1st will be paid a dividend of $0.28 per share on Friday, October 15th. This represents a $1.12 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Thursday, September 30th.
View Encompass Health's dividend history

Is Encompass Health a good dividend stock?

Encompass Health pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.35%. Encompass Health does not yet have a strong track record of dividend growth. The dividend payout ratio of Encompass Health is 38.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Encompass Health will have a dividend payout ratio of 25.34% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health updated its FY21 earnings guidance on Tuesday, July, 27th. The company provided earnings per share (EPS) guidance of $4.32-$4.47 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.11. The company issued revenue guidance of $5.10-$5.25 billion, compared to the consensus revenue estimate of $5.15 billion.

What price target have analysts set for EHC?

7 brokerages have issued 12-month price targets for Encompass Health's shares. Their forecasts range from $94.00 to $110.00. On average, they anticipate Encompass Health's stock price to reach $100.43 in the next year. This suggests a possible upside of 20.6% from the stock's current price.
View analysts' price targets for Encompass Health
or view top-rated stocks among Wall Street analysts.

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 59, Pay $2.17M)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 59, Pay $1.22M)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Barbara Ann Jacobsmeyer, Chief Exec. Officer of Home Health & Hospice (Age 55)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 54)
  • Mr. Rusty Yeager, Chief Information Officer & Sr. VP
  • Ms. Crissy Buchanan Carlisle, CFO of Home Health & Hospice business and Chief Investor Relations Officer
  • Ms. Dawn Rock, Chief Compliance Officer
  • Mr. Anthony A. Hernandez, Chief HR Officer (Age 55)
  • Mr. Frank Brown, Pres of Southwest Region

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health CEO Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among Encompass Health's employees.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include salesforce.com (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD).

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

Who are Encompass Health's major shareholders?

Encompass Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kornitzer Capital Management Inc. KS (0.13%), Oregon Public Employees Retirement Fund (0.03%), State of Alaska Department of Revenue (0.03%), New Mexico Educational Retirement Board (0.02%), Aptus Capital Advisors LLC (0.02%) and Brookstone Capital Management (0.00%). Company insiders that own Encompass Health stock include Andrew L Price, Andrew L Price, Donald L Correll, Donald L Correll, Elissa Joy Charbonneau, Elissa Joy Charbonneau, Mark J Tarr and Mark J Tarr.
View institutional ownership trends for Encompass Health

Which major investors are selling Encompass Health stock?

EHC stock was sold by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS. Company insiders that have sold Encompass Health company stock in the last year include Andrew L Price, and Elissa Joy Charbonneau.
View insider buying and selling activity for Encompass Health
or view top insider-selling stocks.

Which major investors are buying Encompass Health stock?

EHC stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Brookstone Capital Management, New Mexico Educational Retirement Board, CHICAGO TRUST Co NA, Aptus Capital Advisors LLC, and Oregon Public Employees Retirement Fund.
View insider buying and selling activity for Encompass Health
or or view top insider-buying stocks.

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $83.25.

How much money does Encompass Health make?

Encompass Health has a market capitalization of $8.29 billion and generates $4.64 billion in revenue each year. The company earns $284.20 million in net income (profit) each year or $2.89 on an earnings per share basis.

How many employees does Encompass Health have?

Encompass Health employs 43,000 workers across the globe.

When was Encompass Health founded?

Encompass Health was founded in 1984.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

Where are Encompass Health's headquarters?

Encompass Health is headquartered at 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at +1-205-9677116 or via email at [email protected]

This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.